Kira Sheinerman
Vorsitzender bei DiamiR Biosciences Corp.
Profil
Dr. Kira S.
Sheinerman is a Chairman, Secretary & Treasurer at DiamiR Biosciences Corp.
She is on the Board of Directors at Boyce Thompson Institute for Plant Research, Inc. Dr. Sheinerman was previously employed as a Chief Executive Officer by DiamiR LLC.
She also served on the board at TrovaGene, Inc. She received her doctorate degree from Icahn School of Medicine at Mount Sinai.
Aktive Positionen von Kira Sheinerman
| Unternehmen | Position | Beginn |
|---|---|---|
Boyce Thompson Institute for Plant Research, Inc.
 Boyce Thompson Institute for Plant Research, Inc. Miscellaneous Commercial ServicesCommercial Services Boyce Thompson Institute for Plant Research, Inc. provides research and development services. It offers agriculture, environmental and human research services. The company was founded by William Boyce Thompson in 1924 and is headquartered in Ithaca, NY. | Direktor/Vorstandsmitglied | 01.01.2010 |
DiamiR Biosciences Corp.
 DiamiR Biosciences Corp. Medical/Nursing ServicesHealth Services DiamiR Biosciences Corp. operates as a molecular diagnostics company. It focuses on development and commercialization of innovative blood-based tests for detection and monitoring of Mild Cognitive Impairment (MCI), Alzheimer’s disease (AD), Parkinson’s disease (PD), and other neurodegenerative diseases (NDs). The company was founded on June 16, 2014 and is headquartered in Monmouth, NJ. | Vorsitzender | - |
Ehemalige bekannte Positionen von Kira Sheinerman
| Unternehmen | Position | Ende |
|---|---|---|
DiamiR LLC
 DiamiR LLC BiotechnologyHealth Technology Part of DiamiR Biosciences Corp., DiamiR LLC engages in the development and commercialization of technology based on the analysis of brain-enriched microRNA biomarkers in blood plasma. The company is based in Monmouth Junction, NJ. The company was founded by Kira S. Sheinerman. Alidad Mireskandari has been the CEO of the company since 2022. | Vorstandsvorsitzender | 11.07.2022 |
| CARDIFF ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 16.04.2009 |
Ausbildung von Kira Sheinerman
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CARDIFF ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Boyce Thompson Institute for Plant Research, Inc.
Boyce Thompson Institute for Plant Research, Inc. Miscellaneous Commercial ServicesCommercial Services Boyce Thompson Institute for Plant Research, Inc. provides research and development services. It offers agriculture, environmental and human research services. The company was founded by William Boyce Thompson in 1924 and is headquartered in Ithaca, NY. | Commercial Services |
DiamiR LLC
DiamiR LLC BiotechnologyHealth Technology Part of DiamiR Biosciences Corp., DiamiR LLC engages in the development and commercialization of technology based on the analysis of brain-enriched microRNA biomarkers in blood plasma. The company is based in Monmouth Junction, NJ. The company was founded by Kira S. Sheinerman. Alidad Mireskandari has been the CEO of the company since 2022. | Health Technology |
DiamiR Biosciences Corp.
DiamiR Biosciences Corp. Medical/Nursing ServicesHealth Services DiamiR Biosciences Corp. operates as a molecular diagnostics company. It focuses on development and commercialization of innovative blood-based tests for detection and monitoring of Mild Cognitive Impairment (MCI), Alzheimer’s disease (AD), Parkinson’s disease (PD), and other neurodegenerative diseases (NDs). The company was founded on June 16, 2014 and is headquartered in Monmouth, NJ. | Health Services |
